<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2413-4341</journal-id>
<journal-title><![CDATA[Revista Paraguaya de Reumatología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev. parag. reumatol.]]></abbrev-journal-title>
<issn>2413-4341</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Paraguaya de Reumatología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2413-43412021000200034</article-id>
<article-id pub-id-type="doi">10.18004/rpr/2021.07.02.34</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Manifestaciones Autoinmunes en pacientes con COVID-19]]></article-title>
<article-title xml:lang="en"><![CDATA[Autoimmune Manifestations in Patients with COVID-19]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jarolin]]></surname>
<given-names><![CDATA[Dora Montiel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Quintana]]></surname>
<given-names><![CDATA[Auda]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jarolin]]></surname>
<given-names><![CDATA[Magalí]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Riveros]]></surname>
<given-names><![CDATA[César]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ibáñez]]></surname>
<given-names><![CDATA[Elvis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Torres]]></surname>
<given-names><![CDATA[Estela]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Caballero]]></surname>
<given-names><![CDATA[Marlene]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Taboada]]></surname>
<given-names><![CDATA[Verónica]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nuñez]]></surname>
<given-names><![CDATA[Pedro]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ferreira]]></surname>
<given-names><![CDATA[Leticia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Morel]]></surname>
<given-names><![CDATA[Zoilo]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Ministerio de Salud Pública y Bienestar Social Centro Médico Nacional, Hospital Nacional Departamento de Medicina Interna]]></institution>
<addr-line><![CDATA[Itauguá ]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Universidad Nacional de Asunción Facultad de Ciencias Médicas Hospital de Clínicas]]></institution>
<addr-line><![CDATA[San Lorenzo Paraguay]]></addr-line>
<country>Paraguay</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Instituto de Previsión Social Hospital Central Servicio de Reumatología Pediátrica]]></institution>
<addr-line><![CDATA[Asunción ]]></addr-line>
<country>Paraguay</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>12</month>
<year>2021</year>
</pub-date>
<volume>7</volume>
<numero>2</numero>
<fpage>34</fpage>
<lpage>40</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_arttext&amp;pid=S2413-43412021000200034&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_abstract&amp;pid=S2413-43412021000200034&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.iics.una.py/scielo.php?script=sci_pdf&amp;pid=S2413-43412021000200034&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: Introducción: Se han reportado varias manifestaciones autoinmunes en pacientes con COVID -19 agudo o posterior al mismo. El objetivo de este trabajo fue presentar una serie de casos de pacientes con COVID-19 y manifestaciones autoinmunes y autoinflamatorias. Método: Serie de casos de pacientes adultos con COVID-19 agudo o antecedente del mismo, y manifestaciones autoinmunes y autoinflamatorias, internados en el Hospital Nacional de Paraguay, durante el periodo comprendido entre septiembre 2020 y agosto 2021. Resultados: Se presentan diez pacientes con COVID-19 o antecedente cercano del mismo, y manifestaciones autoinmunes, con un promedio de 20 días después de iniciados los síntomas de COVID-19 (rango: 8-30 días). El 40% de los pacientes tenían patologías de base, como hipertensión arterial, obesidad, insuficiencia renal, diabetes, tabaquismo, y uso de drogas ilícitas como cocaína. Ningún paciente tenía antecedentes de enfermedad reumática. La complicación autoinmune más frecuente fue Síndrome de Guillain-Barré (SGB) (40%), seguida por vasculitis. La PCR del SARS-CoV-2 en hisopo nasofaríngeo y orofaríngeo fue positiva en el 80% de los casos, con presencia de Anticuerpos para Sars-Cov-2 en 4 casos. Se encontraron datos de citopenias (anemia severa y plaquetopenia) en aquellos pacientes con lupus eritematoso sistémico (LES), púrpura trombocitopénica trombótica (PTT) y púpura trombocitopenica inmune (PTI). En cuanto a la presencia de anticuerpos, solo fueron positivos: ANA en el paciente con LES y ANCA-c en el paciente con Granulomatosis con Poliangeitis. Tras el tratamiento inmunosupresor con corticoides sistémicos, IGIV, o incluso ciclofosfamida y Micofenolato mofetil según el caso, hubo mejoría clínica, excepto en dos pacientes que fallecieron. Conclusión: El SGB, las manifestaciones autoinmunes hematológicas y las vasculitis fueron las manifestaciones más frecuentes, en relación a la infección por Sars-Cov 2. La mayoría de los pacientes presentó una buena evolución con el tratamiento inmunosupresor.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Introduction: Several autoimmune manifestations concurrent with or following COVID-19 infection have been reported. The purpose of this work is to present a case series of COVID-19 patients with autoimmune or autoinflammatory features. Methods: Case series of adult patients with a history of COVID-19 and autoinmune or autoinflammatory manifestations presenting during or after the acute infection, admitted to the &#8220;Hospital Nacional&#8221; of Paraguay, between September 2020 and August 2021. Results: We present ten patients with a history of COVID-19 infection and autoimmune manifestations, with an average of 20 days between the onset of COVID-19 symptoms and autoimmune manifestations (range: 8-30 days). 40% of the patients had underlying pathologies, such as arterial hypertension, obesity, chronic kidney disease, diabetes, smoking, and illicit drug use (cocaine). No patient had a history of rheumatic disease. The most frequent autoimmune complication was Guillain-Barré Syndrome (GBS) (40%), followed by vasculitis. SARS-CoV-2 PCR in nasopharyngeal or oropharyngeal swabs was positive in 80% of cases. Antibodies to SARS-CoV-2 were detectable in 4 cases. Cytopenias (severe anemia and thrombocytopenia) were found in patients with Systemic Lupus Erythematosus (SLE), Thrombotic Thrombocytopenic Purpura (TTP), and Immune Thrombocytopenic Purpura (ITP). Two patients had autoantibodies: one patient with SLE (ANA) and one patient with Granulomatosis with Polyangiitis (c-ANCA). Eight patients had favorable outcomes with immunosuppressive treatment (systemic corticosteroids, IVIG, cyclophosphamide, and Mycophenolate mofetil). The remaining two patients died. Conclusion: GBS, cytopenias, and vasculitis were the most frequent autoinmune manifestations associated with SARS-CoV-2 infection. Most patients had a favorable outcome with immunosuppressive treatment.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[manifestaciones autoinmunes]]></kwd>
<kwd lng="es"><![CDATA[autoinflamatorias]]></kwd>
<kwd lng="es"><![CDATA[COVID-19]]></kwd>
<kwd lng="es"><![CDATA[SARS-COV-2]]></kwd>
<kwd lng="en"><![CDATA[autoimmune]]></kwd>
<kwd lng="en"><![CDATA[autoinflammatory]]></kwd>
<kwd lng="en"><![CDATA[COVID-19]]></kwd>
<kwd lng="en"><![CDATA[SARS-COV-2]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Zhu]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Zhang]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China]]></article-title>
<source><![CDATA[JAMA]]></source>
<year>2020</year>
<volume>17</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1061-9</page-range></nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hu]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Guo]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Zhou]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Shi]]></surname>
<given-names><![CDATA[ZL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Characteristics of SARS-CoV-2 and COVID-19]]></article-title>
<source><![CDATA[Nat Rev Microbiol]]></source>
<year>2021</year>
<volume>19</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>141-54</page-range></nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="">
<collab>Organización Mundial de la Salud (OMS)</collab>
<source><![CDATA[Alocución de apertura del Director General de la OMS en la rueda de prensa sobre la COVID-19]]></source>
<year>2020</year>
</nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Liu]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Sawalha]]></surname>
<given-names><![CDATA[AH]]></given-names>
</name>
<name>
<surname><![CDATA[Lu]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 and autoimmune diseases]]></article-title>
<source><![CDATA[Curr Opin Rheumatol]]></source>
<year>2021</year>
<volume>33</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>155-62</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ehrenfeld]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tincani]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Andreoli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Cattalini]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Greenbaum]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kanduc]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Covid-19 and autoimmunity]]></article-title>
<source><![CDATA[Autoimmun Rev]]></source>
<year>2020</year>
<volume>19</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>102597</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Novelli]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[De Santis]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Acosta-Ampudia]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Monsalve]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autoinflammatory and autoimmune conditions at the crossroad of COVID-19]]></article-title>
<source><![CDATA[J Autoimmun]]></source>
<year>2020</year>
<volume>114</volume>
<page-range>102506</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Galeotti]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Bayry]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autoimmune and inflammatory diseases following COVID-19]]></article-title>
<source><![CDATA[Nat Rev Rheumatol]]></source>
<year>2020</year>
<volume>16</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>413-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gottlieb]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Long]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Dermatologic manifestations and complications of COVID-19]]></article-title>
<source><![CDATA[Am J Emerg Med]]></source>
<year>2020</year>
<volume>38</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>1715-21</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kösters]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Schwarzer]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Labuhn]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Rübben]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Yang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hessler]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cutaneous Vasculitis in a Patient With COVID-19]]></article-title>
<source><![CDATA[Open Forum Infect Dis]]></source>
<year>2020</year>
<volume>7</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>ofaa474</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Becker]]></surname>
<given-names><![CDATA[RC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19-associated vasculitis and vasculopathy]]></article-title>
<source><![CDATA[J Thromb Thrombolysis]]></source>
<year>2020</year>
<volume>50</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>499-511</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Calabretta]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Moraleda]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Iacobelli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Jara]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Vlodavsky]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[O&#8216;Gorman]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19-induced endotheliitis: emerging evidence and possible therapeutic strategies]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2021</year>
<volume>193</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>43-51</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mayor-Ibarguren]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Feito-Rodriguez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Quintana Castanedo]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz-Bravo]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Montero Vega]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Herranz-Pinto]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cutaneous small vessel vasculitis secondary to COVID-19 infection: a case report]]></article-title>
<source><![CDATA[J Eur Acad Dermatol Venereol]]></source>
<year>2020</year>
<volume>34</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>e541-2</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Camprodon Gómez]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[González-Cruz]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Ferrer]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Barberá]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Leucocytoclastic vasculitis in a patient with COVID-19 with positive SARS-CoV-2 PCR in skin biopsy]]></article-title>
<source><![CDATA[BMJ Case Rep]]></source>
<year>2020</year>
<volume>13</volume>
<numero>10</numero>
<issue>10</issue>
</nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Uppal]]></surname>
<given-names><![CDATA[NN]]></given-names>
</name>
<name>
<surname><![CDATA[Kello]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Shah]]></surname>
<given-names><![CDATA[HH]]></given-names>
</name>
<name>
<surname><![CDATA[Khanin]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[De Oleo]]></surname>
<given-names><![CDATA[IR]]></given-names>
</name>
<name>
<surname><![CDATA[Epstein]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[De Novo ANCA-Associated Vasculitis With Glomerulonephritis in COVID-19]]></article-title>
<source><![CDATA[Kidney Int Rep]]></source>
<year>2020</year>
<volume>5</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>2079-83</page-range></nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Moeinzadeh]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Dezfouli]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Naimi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Shahidi]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Moradi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Newly Diagnosed Glomerulonephritis During COVID-19 Infection Under- going Immunosuppression Therapy, a Case Report]]></article-title>
<source><![CDATA[Iran J Kidney Dis]]></source>
<year>2020</year>
<volume>14</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>239-42</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Powell]]></surname>
<given-names><![CDATA[WT]]></given-names>
</name>
<name>
<surname><![CDATA[Campbell]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Ross]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Peña Jiménez]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Rudzinski]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Dickerson]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute ANCA Vasculitis and Asymptomatic COVID-19]]></article-title>
<source><![CDATA[Pediatrics]]></source>
<year>2021</year>
<volume>147</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B17">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Capes]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bailly]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hantson]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Gerard]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Laterre]]></surname>
<given-names><![CDATA[PF]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 infection associated with autoimmune hemolytic anemia]]></article-title>
<source><![CDATA[Ann Hematol]]></source>
<year>2020</year>
<volume>99</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1679-80</page-range></nlm-citation>
</ref>
<ref id="B18">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lazarian]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Quinquenel]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Bellal]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Siavellis]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Jacquy]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Re]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autoimmune haemolytic anaemia associated with COVID-19 infection]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2020</year>
<volume>190</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>29-31</page-range></nlm-citation>
</ref>
<ref id="B19">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jacobs]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Eichbaum]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 associated with severe auto- immune hemolytic anemia]]></article-title>
<source><![CDATA[Transfusion]]></source>
<year>2021</year>
<volume>61</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>635-40</page-range></nlm-citation>
</ref>
<ref id="B20">
<nlm-citation citation-type="">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopez]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Pandey]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Huang]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[DeLoughery]]></surname>
<given-names><![CDATA[TG]]></given-names>
</name>
</person-group>
<source><![CDATA[Br J Haematol]]></source>
<year>2020</year>
<volume>190</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>31-2</page-range></nlm-citation>
</ref>
<ref id="B21">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jawed]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Hart]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Saeed]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Haemolytic anaemia: a consequence of COVID-19]]></article-title>
<source><![CDATA[BMJ Case Rep]]></source>
<year>2020</year>
<volume>13</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B22">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mantovani Cardoso]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Hundal]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Feterman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Magaldi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Concomitant new diagnosis of systemic lupus erythematosus and COVID-19 with possible antiphospholipid syndrome. Just a coin- cidence? A case report and review of intertwining pathophysiology]]></article-title>
<source><![CDATA[Clin Rheumatol]]></source>
<year>2020</year>
<volume>39</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>2811-5</page-range></nlm-citation>
</ref>
<ref id="B23">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gracia-Ramos]]></surname>
<given-names><![CDATA[AE]]></given-names>
</name>
<name>
<surname><![CDATA[Saavedra-Salinas]]></surname>
<given-names><![CDATA[MÁ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Can the SARS-CoV-2 infection trigger systemic lupus erythematosus? A case-based review]]></article-title>
<source><![CDATA[Rheumatol Int]]></source>
<year>2021</year>
<volume>41</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>799-809</page-range></nlm-citation>
</ref>
<ref id="B24">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hali]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Jabri]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Chiheb]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Hafiani]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Nsiri]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A concomitant diagnosis of COVID-19 infection and systemic lupus erythematosus complicated by a macrophage activation syndrome: A new case report]]></article-title>
<source><![CDATA[Int J Dermatol]]></source>
<year>2021</year>
<volume>60</volume>
<page-range>1030-1</page-range></nlm-citation>
</ref>
<ref id="B25">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zulfiqar]]></surname>
<given-names><![CDATA[AA]]></given-names>
</name>
<name>
<surname><![CDATA[Lorenzo-Villalba]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hassler]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Andrès]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Immune Thrombocytopenic Purpura in a Patient with Covid-19]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>18</numero>
<issue>18</issue>
</nlm-citation>
</ref>
<ref id="B26">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lévesque]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Millaire]]></surname>
<given-names><![CDATA[É]]></given-names>
</name>
<name>
<surname><![CDATA[Corsilli]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rioux-Massé]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Carrier]]></surname>
<given-names><![CDATA[FM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Severeimmune thrombocytopenic purpura in critical COVID-19]]></article-title>
<source><![CDATA[Int J Hematol]]></source>
<year>2020</year>
<volume>112</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>746750</page-range></nlm-citation>
</ref>
<ref id="B27">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bomhof]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Mutsaers]]></surname>
<given-names><![CDATA[PGNJ]]></given-names>
</name>
<name>
<surname><![CDATA[Leebeek]]></surname>
<given-names><![CDATA[FWG]]></given-names>
</name>
<name>
<surname><![CDATA[Te Boekhorst]]></surname>
<given-names><![CDATA[PAW]]></given-names>
</name>
<name>
<surname><![CDATA[Hofland]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Croles]]></surname>
<given-names><![CDATA[FN]]></given-names>
</name>
<name>
<surname><![CDATA[Jansen]]></surname>
<given-names><![CDATA[AJG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19-associated immune thrombocytopenia]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2020</year>
<volume>190</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>e61-4</page-range></nlm-citation>
</ref>
<ref id="B28">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mahévas]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Moulis]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Andres]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Riviere]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Garzaro]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Crickx]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Clinical characteristics, management and outcome of COVID-19-associated immune thrombocytopenia: a French multicentre series]]></article-title>
<source><![CDATA[Br J Haematol]]></source>
<year>2020</year>
<volume>190</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>e224-9</page-range></nlm-citation>
</ref>
<ref id="B29">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lopes da Silva]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Viral-associated thrombotic microangiopathies]]></article-title>
<source><![CDATA[Hematol Oncol Stem Cell Ther]]></source>
<year>2011</year>
<volume>4</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>51-9</page-range></nlm-citation>
</ref>
<ref id="B30">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Albiol]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Awol]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Martino]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Autoimmune thrombotic thrombocytopenic purpura (TTP) associated with COVID-19]]></article-title>
<source><![CDATA[Ann Hematol]]></source>
<year>2020</year>
<volume>99</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>1673-4</page-range></nlm-citation>
</ref>
<ref id="B31">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[AL-Ansari]]></surname>
<given-names><![CDATA[RY]]></given-names>
</name>
<name>
<surname><![CDATA[Bakkar]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Abdalla]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Sewify]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Critical Care COVID-19 Patient with a Picture of Thrombotic Thrombocytopenic Purpura]]></article-title>
<source><![CDATA[Eur J Case Rep Intern Med]]></source>
<year>2020</year>
<volume>7</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>002143</page-range></nlm-citation>
</ref>
<ref id="B32">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Altowyan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Alnujeidi]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Alhujilan]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Alkathlan]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[COVID-19 presenting as thrombotic thrombocytopenic purpura (TTP)]]></article-title>
<source><![CDATA[BMJ Case Rep]]></source>
<year>2020</year>
<volume>13</volume>
<numero>12</numero>
<issue>12</issue>
</nlm-citation>
</ref>
<ref id="B33">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Beaulieu]]></surname>
<given-names><![CDATA[MC]]></given-names>
</name>
<name>
<surname><![CDATA[Mettelus]]></surname>
<given-names><![CDATA[DS]]></given-names>
</name>
<name>
<surname><![CDATA[Rioux- Massé]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Mahone]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Thrombotic thrombocytopenic purpura as the initial presentation of COVID- 19]]></article-title>
<source><![CDATA[J Thromb Haemost]]></source>
<year>2021</year>
<volume>19</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1132-4</page-range></nlm-citation>
</ref>
<ref id="B34">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meppiel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Peiffer-Smadja]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Maury]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Delorme]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Landré]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Petitgars]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Manifestations neurologiques associées à l&#8217;infection SARS-CoV-2 : le registre français NeuroCOVID]]></article-title>
<source><![CDATA[Med Mal Infect]]></source>
<year>2020</year>
<volume>50</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>S20-1</page-range></nlm-citation>
</ref>
<ref id="B35">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Maury]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lyoubi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Peiffer-Smadja]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[de Broucker]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Meppiel]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians]]></article-title>
<source><![CDATA[Rev Neurol (Paris)]]></source>
<year>2021</year>
<volume>177</volume>
<numero>1-2</numero>
<issue>1-2</issue>
<page-range>51-64</page-range></nlm-citation>
</ref>
<ref id="B36">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Toscano]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Palmerini]]></surname>
<given-names><![CDATA[F]]></given-names>
</name>
<name>
<surname><![CDATA[Ravaglia]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ruiz]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Invernizzi]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Cuzzoni]]></surname>
<given-names><![CDATA[MG]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain-Barré Syndrome Associated with SARS- CoV-2]]></article-title>
<source><![CDATA[N Engl J Med]]></source>
<year>2020</year>
<volume>382</volume>
<numero>26</numero>
<issue>26</issue>
<page-range>2574-6</page-range></nlm-citation>
</ref>
<ref id="B37">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abu-Rumeileh]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Abdelhak]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Foschi]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Tumani]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Otto]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain- Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases]]></article-title>
<source><![CDATA[J Neurol]]></source>
<year>2021</year>
<volume>268</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1133-70</page-range></nlm-citation>
</ref>
<ref id="B38">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fragiel]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Miró]]></surname>
<given-names><![CDATA[Ò]]></given-names>
</name>
<name>
<surname><![CDATA[Llorens]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Jiménez]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Piñera]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Burillo]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19]]></article-title>
<source><![CDATA[Ann Neurol]]></source>
<year>2021</year>
<volume>89</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>598-603</page-range></nlm-citation>
</ref>
<ref id="B39">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Trujillo Gittermann]]></surname>
<given-names><![CDATA[LM]]></given-names>
</name>
<name>
<surname><![CDATA[Valenzuela Feris]]></surname>
<given-names><![CDATA[SN]]></given-names>
</name>
<name>
<surname><![CDATA[von Oetinger Giacoman]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Relation between COVID-19 and Guillain-Barré syndrome in adults. Systematic review]]></article-title>
<source><![CDATA[Neurologia (Engl Ed)]]></source>
<year>2020</year>
<volume>35</volume>
<numero>9</numero>
<issue>9</issue>
<page-range>646-54</page-range></nlm-citation>
</ref>
<ref id="B40">
<nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sriwastava S]]></surname>
<given-names><![CDATA[Kataria S]]></given-names>
</name>
<name>
<surname><![CDATA[Tandon M]]></surname>
<given-names><![CDATA[Patel J]]></given-names>
</name>
<name>
<surname><![CDATA[Patel R]]></surname>
<given-names><![CDATA[Jowkar]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Guillain Barré Syndrome and its variants as a manifestation of COVID-19: A systematic review of case reports and case series]]></article-title>
<source><![CDATA[J Neurol Sci.]]></source>
<year>2021</year>
<volume>420</volume>
<page-range>117263</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
